[1] SCHERER P E, WILLIAMS S, FOGLIANO M, et al.A novel serum protein similar to C1q, produced exclusively in adipocytes[J].Journal of Biological Chemistry, 1995, 270(45):26746-26749.
[2] MAEDA K, OKUBO K, SHIMOMURA I, et al.cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1)[J].Biochemical and Biophysical Research Communications, 1996, 221(2):286-289.
[3] NAKANO Y, TOBE T, CHOI-MIURA N H, et al.Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma[J].Journal of Biochemistry, 1996, 120(4):803-812.
[4] ARITA Y, KIHARA S, OUCHI N, et al.Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J].Biochemical and Biophysical Research Communications, 1999, 257(1):79-83.
[5] 唐妮, 王书瑶, 齐锦雯, 等.脂联素调控脂质代谢的研究进展[J].畜牧兽医学报, 2018, 49(12):2550-2557. TANG N, WANG S Y, QI J W, et al.Research progress on adiponectin regulating lipid metabolism[J].Acta Veterinaria et Zootechnica Sinica, 2018, 49(12):2550-2557.(in Chinese)
[6] 张德荣.脂联素及其受体介导绵羊肌内、内脏和皮下脂肪细胞生脂基因表达与分子调控机理研究[D].博士学位论文.兰州:甘肃农业大学, 2019:6-7. ZHANG D R.Adiponectin and its receptors mediated adipogenic gene expression and molecular regulation intramuscular, visceral and subcutaneous adipocytes in sheep[D].Ph.D.Thesis.Lanzhou:Gansu Agricultural University, 2019:6-7.(in Chinese)
[7] GHADGE A A, KHAIRE A A, KUVALEKAR A A.Adiponectin:a potential therapeutic target for metabolic syndrome[J].Cytokine & Growth Factor Reviews, 2018, 39:151-158.
[8] ACHARI A E, JAIN S K.Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction[J].International Journal of Molecular Sciences, 2017, 18(6):1321.
[9] FANG X, PALANIVEL R, ZHOU X, et al.Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts[J].Journal of Molecular Endocrinology, 2005, 35(3):465-476.
[10] KADOWAKI T, YAMAUCHI T.Adiponectin and adiponectin receptors[J].Endocrine Reviews, 2005, 26(3):439-451.
[11] VON FRANKENBERG A D, REIS A F, GERCHMAN F.Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes:a literature review[J].Archives of Endocrinology and Metabolism, 2017, 61(6):614-622.
[12] KHORAMIPOUR K, CHAMARI K, HEKMATIKAR A A, et al.Adiponectin:structure, physiological functions, role in diseases, and effects of nutrition[J].Nutrients, 2021, 13(4):1180.
[13] VASILIAUSKAITÉ-BROOKS I, SOUNIER R, ROCHAIX P, et al.Structural insights into adiponectin receptors suggest ceramidase activity[J].Nature, 2017, 544(7648):120-123.
[14] HUG C, WANG J, AHMAD N S, et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[J].Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(28):10308-10313.
[15] FUKUDA S, KITA S, OBATA Y, et al.The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2[J].Journal of Biological Chemistry, 2017, 292(19):7840-7849.
[16] CHEN T, WU Y W, LU H, et al.Adiponectin enhances osteogenic differentiation in human adipose-derived stem cells by activating the APPL1-AMPK signaling pathway[J].Biochemical and Biophysical Research Communications, 2015, 461(2):237-242.
[17] ENGIN A.Adiponectin-resistance in obesity[J].Advances in Experimental Medicine and Biology, 2017, 960:415-441.
[18] HEIKER J T, WOTTAWAH C M, JUHL C, et al.Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling[J].Cellular Signalling, 2009, 21(6):936-942.
[19] REBHOLZ H, NISHI A, LIEBSCHER S, et al.CK2 negatively regulates Galphas signaling[J].Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(33):14096-14101.
[20] RITTER M, BUECHLER C, KAPINSKY M, et al.Interaction of CD163 with the regulatory subunit of casein kinase Ⅱ (CKⅡ) and dependence of CD163 signaling on CKⅡ and protein kinase C[J].European Journal of Immunology, 2001, 31(4):999-1009.
[21] SAYED M, KIM S O, SALH B S, et al.Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase[J].Journal of Biological Chemistry, 2000, 275(22):16569-16573.
[22] ADAMS D R, RON D, KIELY P A.RACK1, a multifaceted scaffolding protein:structure and function[J].Cell Communication and Signaling, 2011, 9:22.
[23] XU Y Z, WANG N F, LING F, et al.Receptor for activated C-kinase 1, a novel binding partner of adiponectin receptor 1[J].Biochemical and Biophysical Research Communications, 2009, 378(1):95-98.
[24] CHARLTON H K, WEBSTER J, KRUGER S, et al.ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling[J].Biochemical and Biophysical Research Communications, 2010, 392(2):234-239.
[25] KESHVARI S, ROSE F J, CHARLTON H K, et al.Characterisation of the adiponectin receptors:the non-conserved N-terminal region of AdipoR2 prevents its expression at the cell-surface[J].Biochemical and Biophysical Research Communications, 2013, 432(1):28-33.
[26] ESMAILI S, HEMMATI M, KARAMIAN M.Physiological role of adiponectin in different tissues:a review[J].Archives of Physiology and Biochemistry, 2020, 126(1):67-73.
[27] GAMBERI T, MAGHERINI F, MODESTI A, et al.Adiponectin signaling pathways in liver diseases[J].Biomedicines, 2018, 6(2):52.
[28] FANG X P, PALANIVEL R, CRESSER J, et al.An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart[J].American Journal of Physiology:Endocrinology and Metabolism, 2010, 299(5):E721-E729.
[29] 邓大同, 王佑民, 程媛, 等.脂联素通过LKB1途径激活腺苷酸活化蛋白激酶[J].中华内分泌代谢杂志, 2012, 28(7):578-583. DENG D T, WANG Y M, CHENG Y, et al.Adiponectin activates AMP-activated protein kinase via LKB1 pathway[J].Chinese Journal of Endocrinology and Metabolism, 2012, 28(7):578-583.(in Chinese)
[30] YOON M J, LEE G Y, CHUNG J J, et al.Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha[J].Diabetes, 2006, 55(9):2562-2570.
[31] 陈灰, 张良, 李心慰, 等.脂联素对犊牛肝细胞脂氧化关键酶表达的影响[J].中国兽医学报, 2012, 32(10):1551-1555. CHEN H, ZHANG L, LI X W, et al.Effects of adiponectin on the expression of key enzyme genes involved in fatty acid oxidation in bovine hepatocytes cultured
in vitro[J].Chinese Journal of Veterinary Science, 2012, 32(10):1551-1555.(in Chinese)
[32] NGUYEN T M D.Adiponectin:role in physiology and pathophysiology[J].International Journal of Preventive Medicine, 2020, 11:136.
[33] YAMAUCHI T, KAMON J, MINOKOSHI Y, et al.Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J].Nature Medicine, 2002, 8(11):1288-1295.
[34] SHABALALA S C, DLUDLA P V, MABASA L, et al.The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling[J].Biomedicine & Pharmacotherapy, 2020, 131:110785.
[35] IWABU M, YAMAUCHI T, OKADA-IWABU M, et al.Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca
2+ and AMPK/SIRT1[J].Nature, 2010, 464(7293):1313-1319.
[36] CHENG C F, KU H C, LIN H.PGC-1α as a pivotal factor in lipid and metabolic regulation[J].International Journal of Molecular Sciences, 2018, 19(11):3447.
[37] SHIN D J, CAMPOS J A, GIL G, et al.PGC-1alpha activates CYP7A1 and bile acid biosynthesis[J].Journal of Biological Chemistry, 2003, 278(50):50047-50052.
[38] 阳琰, 邓华聪, 龙健, 等.脂联素对HepG2细胞内
PPARα、
ApoA5表达和甘油三酯水平的影响及其机制探讨[J].解放军医学杂志, 2012, 37(7):707-710. YANG Y, DENG H C, LONG J, et al.Effect of adiponectin on
PPARα,
ApoA5 and triglyceride in HepG2 cells and its mechanism[J].Medical Journal of Chinese People's Liberation Army, 2012, 37(7):707-710.(in Chinese)
[39] VAN LINTHOUT S, FORYST-LUDWIG A, SPILLMANN F, et al.Impact of HDL on adipose tissue metabolism and adiponectin expression[J].Atherosclerosis, 2010, 210(2):438-444.
[40] TOMONO Y, HIRAISHI C, YOSHIDA H.Age and sex differences in serum adiponectin and its association with lipoprotein fractions[J].Annals of Clinical Biochemistry, 2018, 55(1):165-171.
[41] YANAI H, YOSHIDA H.Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression:mechanisms and perspectives[J].International Journal of Molecular Sciences, 2019, 20(5):1190.
京公网安备 11010802041926号